Natera (NTRA) Competitors $172.82 -2.32 (-1.32%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$172.88 +0.06 (+0.03%) As of 02/7/2025 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NTRA vs. FMS, HIMS, GH, OPCH, RDNT, BTSG, SHC, VCYT, SGRY, and LFSTShould you be buying Natera stock or one of its competitors? The main competitors of Natera include Fresenius Medical Care (FMS), Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Veracyte (VCYT), Surgery Partners (SGRY), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry. Natera vs. Fresenius Medical Care Hims & Hers Health Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Veracyte Surgery Partners LifeStance Health Group Natera (NASDAQ:NTRA) and Fresenius Medical Care (NYSE:FMS) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, community ranking, media sentiment, analyst recommendations, dividends, earnings and institutional ownership. Do insiders & institutionals believe in NTRA or FMS? 99.9% of Natera shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care shares are held by institutional investors. 7.6% of Natera shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has higher earnings and valuation, NTRA or FMS? Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatera$1.08B21.08-$434.80M-$1.76-98.19Fresenius Medical Care$21.05B0.68$540.07M$1.2120.12 Do analysts rate NTRA or FMS? Natera currently has a consensus price target of $165.88, indicating a potential downside of 4.01%. Fresenius Medical Care has a consensus price target of $25.30, indicating a potential upside of 3.90%. Given Fresenius Medical Care's higher possible upside, analysts clearly believe Fresenius Medical Care is more favorable than Natera.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natera 0 Sell rating(s) 0 Hold rating(s) 17 Buy rating(s) 0 Strong Buy rating(s) 3.00Fresenius Medical Care 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has more risk and volatility, NTRA or FMS? Natera has a beta of 1.66, suggesting that its share price is 66% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Does the media refer more to NTRA or FMS? In the previous week, Natera had 21 more articles in the media than Fresenius Medical Care. MarketBeat recorded 22 mentions for Natera and 1 mentions for Fresenius Medical Care. Natera's average media sentiment score of 0.95 beat Fresenius Medical Care's score of 0.70 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 15 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fresenius Medical Care 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is NTRA or FMS more profitable? Fresenius Medical Care has a net margin of 3.43% compared to Natera's net margin of -14.01%. Fresenius Medical Care's return on equity of 6.04% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Natera-14.01% -26.23% -14.27% Fresenius Medical Care 3.43%6.04%2.69% Does the MarketBeat Community believe in NTRA or FMS? Natera received 61 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 69.04% of users gave Natera an outperform vote while only 54.72% of users gave Fresenius Medical Care an outperform vote. CompanyUnderperformOutperformNateraOutperform Votes48469.04% Underperform Votes21730.96% Fresenius Medical CareOutperform Votes42354.72% Underperform Votes35045.28% SummaryNatera beats Fresenius Medical Care on 10 of the 18 factors compared between the two stocks. Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NTRA vs. The Competition Export to ExcelMetricNateraMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.82B$3.06B$5.70B$9.02BDividend YieldN/A17.74%5.28%4.00%P/E Ratio-98.1916.5389.0018.28Price / Sales21.08176.971,010.11128.72Price / CashN/A427.7437.4433.55Price / Book27.135.174.934.74Net Income-$434.80M-$33.27M$109.11M$223.11M7 Day Performance-2.32%-1.55%-0.29%0.20%1 Month Performance-2.15%-1.68%0.39%-0.08%1 Year Performance148.13%17.89%24.55%21.33% Natera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NTRANatera2.9465 of 5 stars$172.82-1.3%$165.88-4.0%+147.2%$23.12B$1.08B-98.193,293Insider TradePositive NewsFMSFresenius Medical Care3.8576 of 5 stars$24.52-1.4%$25.30+3.2%+23.7%$14.39B$21.05B20.261,358Analyst UpgradeHIMSHims & Hers Health3.2363 of 5 stars$39.21+5.2%$25.13-35.9%+350.0%$8.56B$872M89.071,046Insider TradeNews CoverageGap UpGHGuardant Health3.7572 of 5 stars$47.48+1.1%$42.63-10.2%+101.4%$5.87B$692.26M-11.201,779Gap DownOPCHOption Care Health4.5167 of 5 stars$30.82-0.3%$32.25+4.7%-1.6%$5.25B$4.30B25.927,802Positive NewsRDNTRadNet3.7578 of 5 stars$66.64+1.8%$75.50+13.3%+75.8%$4.93B$1.62B-952.0910,288Gap DownBTSGBrightSpring Health Services2.7449 of 5 stars$23.81+0.9%$19.42-18.4%+92.4%$4.16B$8.83B-91.8335,000SHCSotera Health3.6208 of 5 stars$13.68-0.2%$16.08+17.5%-10.4%$3.87B$1.05B54.723,000Positive NewsVCYTVeracyte3.4707 of 5 stars$45.39-0.2%$42.00-7.5%+70.6%$3.52B$361.05M-303.13790Gap DownSGRYSurgery Partners3.0257 of 5 stars$25.45-0.2%$36.56+43.7%-20.2%$3.23B$2.74B-53.0213,500LFSTLifeStance Health Group0.9832 of 5 stars$8.10+1.6%$8.70+7.5%+31.6%$3.10B$1.06B-31.139,325Positive News Related Companies and Tools Related Companies FMS Competitors HIMS Competitors GH Competitors OPCH Competitors RDNT Competitors BTSG Competitors SHC Competitors VCYT Competitors SGRY Competitors LFST Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NTRA) was last updated on 2/8/2025 by MarketBeat.com Staff From Our PartnersMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis Crypto Is Set to Explode in JanuaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThe Secret Winner in Trump’s AI RevolutionTrump just announced a $500 billion plan to revolutionize artificial intelligence. He's calling it The Star...Behind the Markets | SponsoredCould 1 of these 5 “America First” stocks 26x from here?Tim Bohen says these 5 tiny “America First” stocks are next up in 2025. They’re trading for less than $2 ri...Timothy Sykes | SponsoredElon Musk’s secret rendezvous with Jensen HuangElon Musk is the world's richest person, and it's not even close. Now he's got the ear of President Trump, ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.